Our assessment
TeleClinic names the pharmacy that compounds its medication, and prints the starting dose beside the price so the figure buys a known strength. It also calls its own numbers Intro Pricing rather than dressing them up as standing rates. That last piece of honesty comes with a hole in it. Having called every figure introductory, TeleClinic publishes no renewal rate anywhere, so what month four costs simply isn't on the site.
It names the pharmacy
A line under the price says the product is compounded by a named pharmacy, alongside statements that the physicians are licensed and the records HIPAA-secure. Ninety-four of the four hundred and twenty sellers here name a compounding pharmacy at all.
The Terms go further than most in the other direction too. They say the platform company does not practice medicine and holds no financial relationship with the prescribing physicians that would influence a prescription. That is a specific commitment rather than a general disclaimer, and it is the kind of sentence you can hold a company to.
Intro pricing, and nothing after it
Both treatment pages price a one-month option and a three-month total, and both are labeled Intro Pricing in TeleClinic's own words. The one-month figures are billed monthly at a named starting strength.
What's missing is the renewal. Forty-three of the four hundred and twenty sellers here publish an introductory rate, and the good ones print the standing rate beside it. This one doesn't.
So if you pick TeleClinic on these figures, you are setting a first month against somebody else's ongoing bill. Ask what month four costs before you start.
Forty-seven states, counted but not listed
Both pages state a number of states served and link a state-availability page from the footer. A count is better than nothing, but it isn't a list, and neither priced page names a single state. Two hundred and eighty-six of the four hundred and twenty sellers here publish no service area at all.
A vial-strength selector sits beside the price on each page, offering several strengths. What the introductory figure buys at the higher strengths is never said, which is the other reason the number is narrower than it looks.
No individual prescribing clinician is named, though a medical-team page is linked from the footer.
TeleClinic's published pricing
Prices re-verified September 2026
| Medication | Price |
|---|---|
| MedicationSemaglutide (compounded) — 1 month, 1 mg to start | Price$79/mo$79 a month as introductory pricing at a 1 mg starting dose; the seller doesn't publish the renewal rate |
| MedicationSemaglutide (compounded) — 3 months, total for the first three months | Price$59.67/mo$59.67 a month, from the seller's own $179 introductory total for the first three months; the fourth-month price isn't published |
| MedicationTirzepatide (compounded) — 1 month, 5 mg to start | Price$149/mo$149 a month as introductory pricing at a 5 mg starting dose; the seller doesn't publish the renewal rate |
| MedicationTirzepatide (compounded) — 3 months, total for the first three months | Price$133/mo$133 a month, from the seller's own $399 introductory total for the first three months |
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
See TeleClinic's current price →Who TeleClinic suits
Good fit if
- Readers who want the compounding pharmacy named on the same line as the price.
- Buyers who want a seller to admit, in its own words, that its published figure is introductory.
- People who want a starting strength printed beside a price rather than a bare monthly number.
Look elsewhere if
- Anyone who needs to know what month four costs. No renewal rate is published anywhere on the priced pages.
- Readers who want a named list of states rather than a count.
- Buyers at a higher strength, since what the intro figure buys above the starting dose is never stated.
- People who want an individual prescribing clinician named.
What stands out about TeleClinic
Strengths
- Names the compounding pharmacy that fills the prescription, on the priced page, in one line
- Calls its own promotional rate Intro Pricing rather than presenting it as a standing price
- States a numbered state footprint and links a state-availability page from the same footer
- Publishes a starting dose beside the price, so the figure is scoped to a strength
- States that the platform company does not practice medicine and holds no financial relationship with the prescribing physicians
Trade-offs
- Publishes no renewal rate anywhere on the priced page, having labeled every figure on it introductory
- The forty-seven state claim is a count with no list beside it on the page read
- Names no individual prescribing clinician
- A vial-strength selector sits beside the price, so what the intro figure buys at a higher strength is not established
How this review was verified
- Both treatment pages read.
- TeleClinic labels every figure on both pages Intro Pricing in its own words, and publishes no renewal rate.
- The three-month figure on each page is a total, not a monthly rate.
- Both pages give a number of states and never name one.
- No FDA warning letter under either name. Untitled letters are published separately and were not searched.
Where TeleClinic ranks
TeleClinic qualifies for 3 of the 6 boards on this site. A board only ranks the providers that meet its own condition, so a missing board means TeleClinic does not publish what that board sorts on.
- Semaglutide — #227 of 334
- Tirzepatide — #221 of 319
- Cheapest Overall — #257 of 396
Compare TeleClinic directly
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
| Provider | Score | From/mo | Full review | Action |
|---|---|---|---|---|
| Belle Health | 10.0/10 | From/mo$109Advertised monthly equivalent for a twelve-month supply; not a verified monthly installment. Six-month rate $119, two-month rate $135, one-month rate $199. Confirm the upfront payment and refill schedule. | Full reviewRead the Belle Health review | Visit |
| Midi Health | 10.0/10 | From/mo$164for a 4-week supply, the lowest of four published dose tiers, including shipping | Full reviewRead the Midi Health review | Visit |
| altRx | 8.6/10 | From/mo$89/moadvertised monthly starting price for a multi-dose vial; confirm plan length and checkout total | Full reviewRead the altRx review | Visit |
Frequently asked questions
What happens after the intro period?
TeleClinic doesn't say. Every figure on both treatment pages is labeled Intro Pricing and no renewal rate is published anywhere.
Which pharmacy compounds it?
A named one, printed on the same line as the price on both treatment pages.
Does the price change with the strength?
Not stated. A vial-strength selector sits beside the price, and the page never says what the intro figure buys at the higher strengths.
Does TeleClinic serve my state?
It gives a number of states and links a state-availability page. The priced pages themselves name none.
Who prescribes?
Not named individually. The Terms say the platform company does not practice medicine and holds no financial relationship with the prescribing physicians.
Ready to compare directly?
TeleClinic scores 2.9/10 on this site's rubric. Review the published prices and their conditions above, then confirm your total with the provider. Visiting its site does not commit you to treatment.
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
Visit TeleClinic →